BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 217 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $876,000 | -79.5% | 20,000 | -69.2% | 0.37% | -68.9% |
| Q3 2022 | $4,283,000 | -64.4% | 65,000 | -56.7% | 1.20% | -47.5% |
| Q4 2019 | $12,017,000 | -49.7% | 150,000 | -53.8% | 2.29% | -62.4% |
| Q3 2019 | $23,878,000 | -32.5% | 325,000 | -13.3% | 6.08% | -17.1% |
| Q2 2019 | $35,374,000 | +84.1% | 375,000 | +56.2% | 7.34% | +46.2% |
| Q1 2019 | $19,212,000 | +74.6% | 240,000 | +100.0% | 5.02% | +125.5% |
| Q1 2018 | $11,004,000 | -2.7% | 120,000 | -20.0% | 2.23% | -16.1% |
| Q4 2017 | $11,312,000 | +218.9% | 150,000 | +114.3% | 2.65% | +260.0% |
| Q2 2017 | $3,547,000 | -11.3% | 70,000 | -30.0% | 0.74% | -1.1% |
| Q1 2017 | $3,999,000 | – | 100,000 | – | 0.74% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |